Emerging new therapeutic antibody derivatives for cancer treatment

Monoclonal antibodies constitute a promising class of targeted anticancer agents that enhance natural immune system functions to suppress cancer cell activity and eliminate cancer cells. The successful application of IgG monoclonal antibodies has inspired the development of various types of therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Shijie, Sun, Yanping, Liang, Xiao, Gu, Xinyu, Ning, Jiangtao, Xu, Yingchun, Chen, Shuqing, Pan, Liqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821599/
https://www.ncbi.nlm.nih.gov/pubmed/35132063
http://dx.doi.org/10.1038/s41392-021-00868-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821599/
https://www.ncbi.nlm.nih.gov/pubmed/35132063
http://dx.doi.org/10.1038/s41392-021-00868-x

Ejemplares similares